main-img
Back to Home » June 2021 News » Benign Prostatic Hyperplasia Treatment Market To Be Worth ~$17 Billion by 2030 Says P&S Intelligence

Benign Prostatic Hyperplasia Treatment Market To Be Worth ~$17 Billion by 2030 Says P&S Intelligence

June 24, 2021

NEW YORK, June 24, 2021 /PRNewswire/ -- The global benign prostatic hyperplasia treatment market is expected to reach a value of around $17 billion by 2030. The surging geriatric population, rising incidence of prostate cancer, growing awareness about prostate cancer and its treatment...

Source URL: https://www.prnewswire.com:443/news-releases/benign-prostatic-hyperplasia-treatment-market-to-be-worth-17-billion-by-2030-says-ps-intelligence-301319088.html
Browse News